Home » Authors » Trista Morrison

Articles by Trista Morrison

Aegera Acquires LymphoSign, Completes Series C Financing

Aug. 9, 2007

By Trista Morrison

Aegera Acquires LymphoSign, Completes Series C Financing

Aug. 9, 2007

By Trista Morrison

Cash-Poor IsoTis Acquired By Integra In $51M Deal

Aug. 8, 2007

By Trista Morrison

Cash-Poor IsoTis Acquired By Integra In $51M Deal

Aug. 8, 2007

By Trista Morrison

Curis Raises $13 Million To Support Cancer Programs

Aug. 7, 2007

By Trista Morrison

Curis Raises $13 Million To Support Cancer Programs

Aug. 7, 2007

By Trista Morrison

Regeneron, Bayer Start Phase III With VEGF Trap-Eye In Wet AMD

Aug. 6, 2007

By Trista Morrison

Regeneron, Bayer Start Phase III With VEGF Trap-Eye In Wet AMD

Aug. 6, 2007

By Trista Morrison

Diagnostic lab Genoptix files for IPO of up to $86.25 million

Aug. 3, 2007

By Trista Morrison

Pozen Plummets On Second Approvable Letter For Trexima

Aug. 3, 2007

By Trista Morrison

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...